Category: Biotechnology
Global Biotechnology
-
CAR T-cell Therapy
... at a CAGR of 22.0% over the analysis period 2024-2030. DLBCL, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$5.1 Billion by the end of the ... Read More
-
Humanized Mouse and Rat Model
... Million by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Oncology, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$74.5 Million by ... Read More
-
In Situ Hybridization (ISH)
... 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Fluorescence In Situ Hybridization (FISH), one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.1 ... Read More
-
Microplate Systems
... CAGR of 4.6% over the analysis period 2024-2030. Readers, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$851.2 Million by the end of the analysis period. ... Read More
-
Optical Emission Spectroscopy (OES)
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$718.1 Million by the end ... Read More
-
Digestive Enzyme Supplements
... at a CAGR of 5.9% over the analysis period 2024-2030. Additional Supplements, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.2 Billion by the end of ... Read More
-
DNA Sequencing
... CAGR of 11.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end of the analysis period. ... Read More
-
Downstream Processing
... CAGR of 15.6% over the analysis period 2024-2030. Purification, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$60.6 Billion by the end of the analysis period. ... Read More
-
Electron Microscopy and Sample Preparation
... Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Industrial, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$3.2 Billion by ... Read More
-
Proteases
... 5.5% over the analysis period 2024-2030. Microbes, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in ... Read More
-
Gel Documentation Systems
... at a CAGR of 4.1% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$173.1 Million by the end of the ... Read More
-
Genomics
... 19.0% over the analysis period 2024-2030. Sequencing, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$106.1 Billion by the end of the analysis period. Growth in ... Read More
-
Grain Analysis
... CAGR of 4.8% over the analysis period 2024-2030. Cereals, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.2 Billion by the end of the analysis period. ... Read More
-
RNA Analysis / Transcriptomics
... 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$9.7 Billion by ... Read More
-
Transfection Reagents and Equipment
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.2 Billion by the end ... Read More
-
In Vitro Protein Expression Systems
... Million by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. E-Coli, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$162.9 Million by ... Read More
-
Ion Chromatography
... CAGR of 6.9% over the analysis period 2024-2030. Ion-Exchange Chromatography, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$2.6 Billion by the end of the analysis ... Read More
-
Life Science Instrumentation
... at a CAGR of 4.6% over the analysis period 2024-2030. Spectroscopy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$24.4 Billion by the end of the ... Read More
-
Fill Finish Manufacturing
... at a CAGR of 8.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$13.7 Billion by the end of the ... Read More
-
Glycomics / Glycobiology
... at a CAGR of 16.9% over the analysis period 2024-2030. Enzymes, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
Cold Plasma
... CAGR of 14.7% over the analysis period 2024-2030. Polymer & Plastics, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Computational Biology
... CAGR of 18.0% over the analysis period 2024-2030. Drug Discovery & Disease Modelling, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$15.7 Billion by the end ... Read More
-
Induced Pluripotent Stem Cell (iPSC)
... Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Vascular Cells, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.1 Billion ... Read More
-
Combination Antibody Therapy
... at a CAGR of 14.0% over the analysis period 2024-2030. Chemotherapy / Antibody, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$169.7 Billion by the end ... Read More
-
Allogeneic Stem Cells
... at a CAGR of 10.9% over the analysis period 2024-2030. Regenerative Therapy, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$1.6 Billion by the end of ... Read More
Research Assistance
